Redrow Plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Redrow Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8837
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Redrow Plc – Strategy, SWOT and Corporate Finance Report
Summary

Redrow Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Redrow Plc (Redrow) is a residential property developer. The company carries out the development of community properties. It has land across the UK, which includes Lancashire, Yorkshire, North West, East Midlands, Midlands, South Wales, South West, South Midlands, Eastern, Greater London, South Counties and South East. The company through Harrow Estates Plc carries out acquisition, problem solving, regeneration and commercial development of land and property. It portfolio of property includes Woodford Garden Village, Cheshire; Ebbsfleet Green, Kent; Plasdwr, Cardiff; Colindale Gardens, North London; and Amington Garden Village, Tamworth. The company through its subsidiaries operates in the UK. Redrow is headquartered in Ewloe, Flintshire, the UK.

Scope

- Detailed information on Redrow Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Redrow Plc in the form of a SWOT analysis
- An in-depth view of the business model of Redrow Plc including a breakdown and examination of key business segments
- Intelligence on Redrow Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Redrow Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Redrow Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Redrow Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Redrow Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Redrow Plc: Company Overview 9
Redrow Plc: Overview and Key Facts 9
Redrow Plc: Overview 9
Redrow Plc: Key Facts 9
Redrow Plc: Key Employees 11
Redrow Plc: Key Employee Biographies 12
Redrow Plc: Major Products and Services 15
Redrow Plc: Company History 16
Redrow Plc: Management Statement 18
Redrow Plc: Locations and Subsidiaries 21
Redrow Plc: Key Competitors 23
Redrow Plc: Company Analysis 24
Redrow Plc: Business Description 24
Redrow Plc: SWOT Analysis 25
Redrow Plc: SWOT Overview 25
Redrow Plc: Strengths 25
Redrow Plc: Weaknesses 26
Redrow Plc: Opportunities 26
Redrow Plc: Threats 27
Redrow Plc: Corporate Financial Deals Activity 28
Redrow Plc: Financial Deals Overview 28
Redrow Plc: Targets and Partners 29
Redrow Plc: Top Deals 2014 – 2018YTD* 30
Redrow Plc: Mergers and Acquisitions 31
Redrow Plc: Partnership 32
Redrow Plc: Recent Developments 33
Redrow Plc: News and Events Summary 33
Redrow Plc: Business Expansion 34
Redrow Plc: Corporate Governance 35
Redrow Plc: Financial Performance 35
Redrow Plc: Regulatory and Legal Events 36
Redrow Plc: Strategy and Operations 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: Redrow Plc: Key Facts
Table 2: Redrow Plc: Key Employees
Table 3: Redrow Plc: Company History
Table 4: Redrow Plc: Locations and Subsidiaries
Table 5: Redrow Plc: Key Competitors
Table 6: Redrow Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Redrow Plc: Targets and Partners
Table 8: Redrow Plc: Top Deals 2014 - 2018YTD*
Table 9: Redrow Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Redrow Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Redrow Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 12: Redrow Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 13: Redrow Plc: News and Events Summary
Table 14: Redrow Plc: Business Expansion
Table 15: Redrow Plc: Corporate Governance
Table 16: Redrow Plc: Financial Performance
Table 17: Redrow Plc: Regulatory and Legal Events
Table 18: Redrow Plc: Strategy and Operations

List of Figures
Figure 1: Redrow Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Redrow Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Redrow Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Redrow Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Redrow Plc: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Redrow Plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AngioChem Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AngioChem Inc (AngioChem) is a clinical-stage biotechnology company that discovers and develops new drugs to treat brain related disorders. The company’s products comprise oncology products, peptide antibody conjugates, antibody-drug conjugates, pain products and lysosomal storage diseases p …
  • Health Dialog Services Corp:企業の戦略的SWOT分析
    Health Dialog Services Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Alliance Bernstein Private Clients:企業の戦略・SWOT・財務情報
    Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report Summary Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Central Rand Gold Ltd:企業の戦略・SWOT・財務情報
    Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Boehringer Ingelheim GmbH-医療機器分野:企業M&A・提携分析
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer healt …
  • Geron Corp (GERN)-製薬・医療分野:企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Radiomedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that provides therapies. The company provides radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. Its products include smartmedix system and glucomedix. Radiomedix’s services include CGMP drug manufacturing suite and mi …
  • Sigdo Koppers SA:企業の戦略・SWOT・財務情報
    Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report Summary Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Puma Energy Holdings Pte Ltd:企業の戦略的SWOT分析
    Puma Energy Holdings Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Hyundai Rotem Co
    Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cardno Ltd:企業のM&A・事業提携・投資動向
    Cardno Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cardno Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • j2 Global, Inc.:企業のM&A・事業提携・投資動向
    j2 Global, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's j2 Global, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Vivergo Fuels Limited:企業の戦略的SWOT分析
    Vivergo Fuels Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Virgin Active Limited
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gol Linhas Aereas Inteligentes SA :企業の戦略・SWOT・財務情報
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Biocodex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex is a manufacturer and distributor probiotic drug products. The company’s products include Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a yeast-based probiotic that helps ke …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆